Tripos Discovery Research

Integrated Drug Discovery Services

Tripos Discovery Research's knowledge driven drug discovery services uniquely combine the disciplines of medicinal chemistry, biology and predictive assay technology with proprietary Tripos software such as LeadHopping® and ChemSpace® to augment the identification and development of novel, biologically active compounds in reduced time-frames.

HTAPq

(High Throughput Analysis, Purification and Quantitation)

Tripos Discovery Research offers one of the most advanced high throughput analysis and purification services available. Internally and externally validated, our processes are tailored to each class of compound, ensuring maximum recovery and purity. Integrated into all our discovery programmes, they are also offered as a stand alone service to improve the integrity of clients' corporate and legacy collections - greatly enhancing their value in future screening programmes.

LeadDiscovery

Kinase and GPCR solutions tailored to address your target. Tripos Discovery Research has invested significant R&D effort to establish a rich seam of early-stage, novel chemistry assets containing chemotypes with confirmed activity towards both kinase and GPCR disease targets. Offering you a route straight to lead optimisation for these targets, compounds can be accessed under two business models.

LeadQuest

Through its LeadQuest® brand, Tripos Discovery Research is a world-leading provider of library screening compounds, with over 300 clients in more than 25 countries.

LeadSelect™ - NEW - commission us to build focused screening libraries specific to your requirements
LeadQuest volume 4 – up to 30,000 brand new screening compounds available off-the-shelf for library screening
LeadScreen™ - preformatted screening sets, sizes between 6,000 and 50,000, available for library screening at Tripos Discovery Research or at your facility